67 results
424B5
COGT
Cogent Biosciences Inc
30 Nov 20
Prospectus supplement for primary offering
5:28pm
;
the pricing and reimbursement of our product candidates, if approved;
regulatory developments in the United States and foreign countries;
our ability … to the general public and may also impose limitations on its promotional activities with healthcare professionals.
Pricing and Reimbursement
424B5
COGT
Cogent Biosciences Inc
2 Dec 20
Prospectus supplement for primary offering
5:06pm
;
the rate and degree of market acceptance of our product candidates, if approved;
the pricing and reimbursement of our product candidates, if approved … limitations on its promotional activities with healthcare professionals.
Pricing and Reimbursement Environment
Even if a pharmaceutical product
8-K
EX-10.1
COGT
Cogent Biosciences Inc
5 Aug 19
Entry into a Material Definitive Agreement
5:27pm
to secure reimbursement obligations under corporate credit cards. For the avoidance of doubt, no account control agreements in favor of Bank shall … on Cash in a collateral account with Silicon Valley Bank in an amount not to exceed $250,000 at any time securing reimbursement obligations under a credit
8-K
EX-10.1
e56b5x3wfg
27 Dec 21
Departure of Directors or Certain Officers
4:05pm
8-K
EX-10.3
xr1n1c0 bf0m
6 Jul 20
Unum Therapeutics Inc. Announces Acquisition of Kiq LLC
10:31am
8-K
EX-10.2
0u0kemgfaclja7ijfa3
27 Dec 21
Departure of Directors or Certain Officers
4:05pm
10-K
zu0g5ud4l
28 Mar 19
Annual report
7:31am